Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronomodulation of Ketoprofen for Bone Healing
NCT03911336Phase 4Withdrawn
- Sponsor
- University of Iowa
- Start
- Jan 2023
- Primary completion
- Jan 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ketoprofen in tooth loss (3 arms), sponsored by University of Iowa. Primary endpoint: Proportion of mineralized tissue at 6 weeks. Planned start Jan 2023; status: withdrawn.
02
Drugs
ketoprofen
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT03911336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03911336.